Home
>
National Drug Code (NDC)
>
NovoSeven
NovoSeven - 0169-7020-01 - (Coagulation Factor VIIa (Recombinant))
Drug Information of NovoSeven
| Product NDC: | 0169-7020 |
| Proprietary Name: | NovoSeven |
| Non Proprietary Name: | Coagulation Factor VIIa (Recombinant) |
| Active Ingredient(s): | & nbsp; Coagulation Factor VIIa (Recombinant) |
| Administration Route(s): | |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of NovoSeven
| Product NDC: | 0169-7020 |
| Labeler Name: | Novo Nordisk |
| Product Type: | PLASMA DERIVATIVE |
| FDA Application Number: | BLA103665 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20080430 |
Package Information of NovoSeven
| Package NDC: | 0169-7020-01 |
| Package Description: | 1 KIT in 1 KIT (0169-7020-01) * 2.1 mL in 1 VIAL, GLASS * 2.1 mL in 1 VIAL, GLASS |
NDC Information of NovoSeven
| NDC Code | 0169-7020-01 |
| Proprietary Name | NovoSeven |
| Package Description | 1 KIT in 1 KIT (0169-7020-01) * 2.1 mL in 1 VIAL, GLASS * 2.1 mL in 1 VIAL, GLASS |
| Product NDC | 0169-7020 |
| Product Type Name | PLASMA DERIVATIVE |
| Non Proprietary Name | Coagulation Factor VIIa (Recombinant) |
| Dosage Form Name | KIT |
| Route Name | |
| Start Marketing Date | 20080430 |
| Marketing Category Name | BLA |
| Labeler Name | Novo Nordisk |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |
